The following impurities are available with SUMA Laboratories Pvt Limited. Click here to Download our impurities in pdf format...
Product list 51 - 100:
| S.No | Compound Name | CAS | Remarks |
|---|---|---|---|
| 51 | 2-[(11Z)-11-[3-(Dimethylamino) propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetaldehyde | Olopatadine Carbaldehyde. Hydrochloride | |
| 52 | (11E)-11-[3-(Dimethyl amino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic Acid Hydrochloride | 949141-22-4 Free Base: 113806-06-7 | Olopatadine E-isomer |
| 53 | (11Z)-(3-(Dimethyl amino) propylidene)-6, 11-dihydrodibenzo [b, e] oxepin-2-N, N-dimethylacetamide; (11Z)-11-[3-(dimethylamino)propylidene]-6,11-dihydro-N,N-dimethyl-Dibenz[b,e]oxepin-2-acetamide | 872041-02-6 | Olopatadine Amide |
| 54 | (11Z)-11-[3-(Dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetamide | 872040-99-8 | Olopatadine Amide |
| 55 | 5-(Diphenylphosphoryl)pentanoic acid | 71140-70-0 | Latanoprost impurity |
| 56 | Methyl 5-(diphenylphosphoryl)pentanoate | 146964-27-4 | Latanoprost impurity |
| 57 | (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(3R)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoic acid | 41639-83-2 | Latanoprost Acid |
| 58 | (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-(3-oxo-5-phenylpentyl)cyclopentyl]hept-5-enoic acid | 369585-22-8 | Latanoprost Acid |
| 59 | 5,6-trans-Latanoprost | 913258-34-1 | 5,6-trans-Latanoprost |
| 60 | Propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxy-5-phenylpentyl]cyclopentyl]hept-5-enoate | 145773-22-4 | 15(S)-Latanoprost |
| 61 | 4,6-Dichloro-2-methylsulfanylpyrimidine | 6299-25-8 | Alogliptin impurity |
| 62 | 2-((4,6-Dichloropyrimidin-2-yloxy)methyl)benzonitrile | NA | Alogliptin impurity |
| 63 | 2-((4,6-Dimethoxypyrimidin-2-yloxy)methyl)benzonitrile | NA | Alogliptin impurity |
| 64 | 2,2'-(((6-Chloropyrimidine-2,4-diyl)bis(oxy))bis(methylene))dibenzonitrile | NA | Alogliptin impurity |
| 65 | (6-Chloro-2-(methylthio)pyrimidin-4-ol) | NA | Alogliptin impurity |
| 66 | 2-[[5-Methoxy-1-[4-(trifluoromethyl)phenyl] pentylidene]amino]oxyethanamine | 917096-37-8 | Fluvoxamine impurity B |
| 67 | 1-Azabicyclo[2.2.2]octan-3-yl 2-hydroxy-2,2-diphenylacetate | 6581-06-2 | Oxybutynin impurity |
| 68 | Methyl 2-hydroxy-2,2-diphenylacetate | 76-89-1 | Oxybutynin impurity |
| 69 | 4-(Diethylamino)but-2-ynyl 2-hydroxy-2,2-diphenylacetate | 14943-53-4 | Oxybutynin EP Impurity B |
| 70 | 4-[Ethyl(methyl)amino]but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate | 1199574-70-3 | Oxybutynin Impurity C |
| 71 | Methyl 2-cyclohexyl-2-hydroxy-2-phenylacetate | 10399-13-0 | Oxybutynin Impurity 1 (Cyclohexyl Mandelic Acid Methyl Ester) |
| 72 | Ethyl 2-cyclohexyl-2-hydroxy-2-phenylacetate | 31197-69-0 | Oxybutynin Impurity 2 (Phenylcyclohexylglycolic Acid Ethyl Ester) |
| 73 | 2-(1-Cyanocyclohexyl) acetic acid | 133481-09-1 | Gabapentin impurity B |
| 74 | 2-[1-[(3-Oxo-2-azaspiro [4.5]decan-2-yl)methyl]cyclohexyl]acetic acid | 1076198-17-8 | Gabapentin impurity D |
| 75 | 2-(Cyclohexanecarbonyloxy)acetic acid | 667465-00-1 | Gabapentin impurity E |
| 76 | 2-(1-(2-Aminoethyl)cyclohexyl)acetic acid | 1500558-49-5 | Gabapentin impurity G |
| 77 | (3R,5R)-7-[3-(Phenylcarbamoyl)-2-isopropyl-4,5-diphenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid calcium salt | 433289-83-9 | Atorvastatin related compound A |
| 78 | calcium;(3S,5R)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate | 887196-25-0 | Atorvastatin related compound B |
| 79 | calcium;(3R,5R)-7-[2,3-Bis(4-fluorophenyl)-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate | 693793-53-2 | Atorvastatin Related compound C. |
| 80 | 3-(4-Fluorobenzoyl)-2-isobutyryl-N,3-diphenyloxirane-2-carboxamide | 148146-51-4 | Atorvastatin Related compound D Atorvastatin Degradation Product - ATV-FXA1 Atorvastatin Diketo Epoxide |
| 81 | 3S,5S)-7-[2-(4-Fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid | 1428118-38-0-salt Free Acid: 501121-34-2 | Atorvastatin EP Impurity E |
| 82 | (3R,5R)-7-[[(3R,5R)-7-[2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]-3,5-dihydroxy-1-oxoheptyl]amino]-3,5-dihydroxy-heptanoic Acid | 887196-24-9-salt free base: 887196-24-9 | Atorvastatin EP Impurity F |
| 83 | 5-(4-Fluorophenyl)-1-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-N,4-diphenyl-2-propan-2-ylpyrrole-3-carboxamide | 125995-03-1 | Atorvastatin related compound H |
| 84 | tert-Butyl [(4R,6R)-6-[2-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate | 125971-95-1 | Atorvastatin related compound I |
| 85 | 4-[7-(4-fluorophenyl)-7-hydroxy-7a-phenyl-1a-(phenylcarbamoyl)-1b-propan-2-yl-4,5-dihydro-3H-oxireno[1,2]pyrrolo[4,5-b][1,3]oxazin-3-yl]-3-hydroxybutanoic acid | 1316291-19-6 | Atorvastatin FXA Impurity (Atorvastatin epoxy pyrrolooxazin 6-hydroxy analog |
| 86 | 4-(1b-(4-Fluorophenyl)-7-hydroxy-7-isopropyl-1a-phenyl-7a-(phenylcarbamoyl)hexahydro-3H-oxireno[2',3':3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoic acid | 873950-18-6; 1315629-79-8(Sodium Salt) | Atorvastatin FX1 Impurity (Atorvastation epoxy pyrrolooxazin 7-hydroxy) analog |
| 87 | 4-(4-Fluorophenyl)-2,4-dihydroxy-N,5-diphenyl-2-propan-2-yl-3,6-dioxabicyclo[3.1.0]hexane-1-carboxamide | 873950-19-7 | Atorvastatin Epoxy Tetrahydrofuran Analog |
| 88 | 3-(4-Fluorobenzoyl)-2-(2-methylpropyl)-N,3-diphenyloxirane-2-carboxamide | 1246818-88-1 | Atorvastatin Oxirane Impurity |
| 89 | tert -Butyl (3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoate | 134395-00-9 | Atorvastatin tert-Butyl Ester |
| 90 | Atorvastatin Dehydro Lactone | 442851-50-5 | Atorvastatin Dehydro Lactone |
| 91 | Atorvastatin Ethyl Ester | 1146977-93-6 | Atorvastatin Ethyl Ester |
| 92 | Bumetanide intermediate | NA | Bumetanide intermediate |
| 93 | 3-(2-Ethylhexylamino)-4-phenoxy-5-sulfamoylbenzoic acid | 153012-65-8 | Bumetanide impurity |
| 94 | (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-prop-1-en-2-yl-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate | 879562-26-2 | Olmesartan -EP impurity C |
| 95 | 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2’-(1H-tetazol-5-yl)[1,1’-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid | 144689-24-7 | Olmesartan EP Impurity A |
| 96 | 3,6-Dihydro-6,6-dimethyl-2-propyl-3-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-4H-Furo[3,4-d]imidazol-4-one | 849206-43-5 | Olmesartan Lactone Impurity |
| 97 | 4-(1-Methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic Acid | 172875-98-8 | Dehydro Olmesartan |
| 98 | (S)-2-(6-Hydroxy-2-naphthyl)propionic Acid | 52079-10-4 | Naproxen EP Impurity A |
| 99 | (S)-5-Chloro-6-methoxy-α-methyl-2-naphthaleneacetic Acid | 89617-86-7 | Naproxen EP Impurity B |
| 100 | (S)-5-Bromo-6-methoxy-α-methyl-2-naphthaleneacetic Acid | 84236-26-0 | Naproxen EP Impurity C |
Suma Laboratories ® All rights reserved.